CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in Multiple Myeloma
Sara Yousef(Huntsman Cancer Institute), Djordje Atanackovic(University of Maryland, Baltimore), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), Mary Steinbach(University of Utah), Tim Luetkens(University of Maryland, Baltimore), Amanda Langemo(University of Utah), N. Bhardwaj(University of Utah), Michael Binder, Magdalena Kovacsovics-Bankowski, Tibor Kovacsovics(Hôpital Edouard Herriot), Nicolaus Kröger(Universität Hamburg), James Marvin(University of Utah), Jens Panse(University Hospital Cologne)
Cited by 1
Related Papers
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|619
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial
|Journal of Clinical Oncology|2004|547
Spectrum of Epithelial Neoplasms in End-Stage Renal Disease
|The American Journal of Surgical Pathology|2006|484
A genetic mechanism for Tibetan high-altitude adaptation
|Nature Genetics|2014|441
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
|Bone Marrow Transplantation|2016|396